1. Home
  2. IMRN vs PLAG Comparison

IMRN vs PLAG Comparison

Compare IMRN & PLAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • PLAG
  • Stock Information
  • Founded
  • IMRN 1994
  • PLAG 1986
  • Country
  • IMRN Australia
  • PLAG United States
  • Employees
  • IMRN N/A
  • PLAG N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • PLAG Packaged Foods
  • Sector
  • IMRN Health Care
  • PLAG Consumer Staples
  • Exchange
  • IMRN Nasdaq
  • PLAG Nasdaq
  • Market Cap
  • IMRN 10.1M
  • PLAG 10.0M
  • IPO Year
  • IMRN N/A
  • PLAG N/A
  • Fundamental
  • Price
  • IMRN $1.72
  • PLAG $1.38
  • Analyst Decision
  • IMRN Strong Buy
  • PLAG
  • Analyst Count
  • IMRN 1
  • PLAG 0
  • Target Price
  • IMRN $5.00
  • PLAG N/A
  • AVG Volume (30 Days)
  • IMRN 22.7K
  • PLAG 126.3K
  • Earning Date
  • IMRN 05-06-2025
  • PLAG 05-14-2025
  • Dividend Yield
  • IMRN N/A
  • PLAG N/A
  • EPS Growth
  • IMRN N/A
  • PLAG N/A
  • EPS
  • IMRN N/A
  • PLAG N/A
  • Revenue
  • IMRN $4,048,286.00
  • PLAG $6,729,937.00
  • Revenue This Year
  • IMRN N/A
  • PLAG N/A
  • Revenue Next Year
  • IMRN N/A
  • PLAG N/A
  • P/E Ratio
  • IMRN N/A
  • PLAG N/A
  • Revenue Growth
  • IMRN 82.90
  • PLAG N/A
  • 52 Week Low
  • IMRN $1.60
  • PLAG $1.00
  • 52 Week High
  • IMRN $2.87
  • PLAG $5.52
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 46.67
  • PLAG 46.50
  • Support Level
  • IMRN $1.64
  • PLAG $1.20
  • Resistance Level
  • IMRN $1.91
  • PLAG $1.76
  • Average True Range (ATR)
  • IMRN 0.16
  • PLAG 0.25
  • MACD
  • IMRN 0.00
  • PLAG 0.04
  • Stochastic Oscillator
  • IMRN 31.00
  • PLAG 45.95

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About PLAG Planet Green Holdings Corp.

Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.

Share on Social Networks: